Problem To provide a therapeutic agent for estrogen dependent gynecological disorders such as endometriosis uterine fibroids and adenomyosis. Solution An estrogen receptor ?? inhibiting ?? partial agonist represented by structural formula (a) a pharmaceutically acceptable salt thereof or a hydrate of either of the aforementioned is used as an active ingredient.